Omeros Corporation to Announce Third Quarter Financial Results on November 16, 2026
Business Wire•10/11/2026•16:02 ET
0
Key Highlights
- ➤Omeros to report third-quarter 2026 financial results November 16 after market close
- ➤Management conference call and webcast scheduled for 4:30 p.m. Eastern Time
- ➤YARTEMLEA FDA-approved and commercially available for TA-TMA in U.S. patients
- ➤Novo Nordisk acquired global rights to zaltenibart, formerly OMS906
Omeros Corporation to Announce Third Quarter Financial Results on November 16, 2026
Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the third quarter of 2026 on Monday, November 16, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results.
Get started
Create a free account to read the full story.